The Hennessy Group Announces Rare Disease Leadership Placements at Amicus Therapeutics and Eloxx Pharmaceuticals

Friday, August 9, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Recent leadership placements at Amicus Therapeutics and Eloxx Pharmaceuticals illustrate the importance of clinical and scientific research in the life sciences industry today.

PARK CITY, Utah, Aug. 9, 2019 /PRNewswire-PRWeb/ -- The Hennessy Group, an executive search firm specializing in the

life sciences industry, announced the placement of new, key members of the science and leadership teams at Eloxx Pharmaceuticals and Amicus Therapeutics.

Eloxx Pharmaceuticals has selected Dan Crawford to serve as its Principal Scientist for Pharmacology and Translational Sciences. Dr. Crawford holds a Ph.D. in neuroscience from USC and has previously worked as a research and senior scientist with Vertex Pharmaceuticals and the EMD Serono Research and Development Institute. In his role with Eloxx, Dr. Crawford will focus his responsibilities on model-based drug development. Eloxx Pharmaceuticals, Ltd., is a global biopharmaceutical company with its U.S. headquarters in Waltham, Massachusetts. The company was founded in 2013 to develop treatments for rare and ultra-rare genetic diseases.

Maria Alba, MD, will join the team at Amicus Therapeutics as the firm's Executive Director of Pompe Clinical Research. Prior to joining Amicus, Dr. Alba was Senior Director of Clinical Research for Cardiovascular and Metabolism at Janssen R&D, and began her commercial life sciences career as Director of Clinical Research-Metabolism at Merck. With Amicus, Dr. Alba will drive the global development strategy and execution of the firm's Pompe program, including drug development strategy, clinical study design, and participation in the regulatory process. Amicus Therapeutics, Inc., is a global biotechnology company with a development pipeline of treatments and therapies to treat a range of human genetic diseases, including rare and orphan diseases.

"While the competition for these roles was impressive, both Ms. Alba and Mr. Crawford were able to show their ability to lead critical programs for Eloxx and Amicus through their previous contributions to the life sciences community. They're ideal leaders for these two growing companies -- expect to see great things," said Robert Hennessy, CEO of The Hennessy Group.

About The Hennessy Group: The Hennessy Group is a retained executive search firm conducting in-depth searches for executives, CEOs and board directors in the life sciences industry, both domestically and worldwide. With more than 30-years' experience, The Hennessy Group offers guaranteed search success for U.S. companies in the pharmaceutical, biotechnology, medical devices, and diagnostics industries, and recently entered into a partnership to provide placement services in the East Asian life sciences market. Learn more about The Hennessy Group at http://www.thehennessygroup.com.

 

SOURCE The Hennessy Group



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store